Filing Details

Accession Number:
0001055726-21-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-21 18:00:41
Reporting Period:
2021-04-21
Accepted Time:
2021-04-21 18:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1259780 Peter Kies C/O Inovio Pharmaceuticals, Inc.
6769 Mesa Ridge Road
San Diego CA 92121
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-21 10,000 $8.52 160,788 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,500 Indirect By Spouse
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. These transactions were executed in multiple trades at prices ranging from $8.49 to $8.56, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.